NEW YORK, April 1, 2016 /PRNewswire-USNewswire/ -- More patients will die from pancreatic cancer than breast cancer this year, moving pancreatic cancer from the fourth to the third-leading cause of cancer-related death in the United States, according to the Cancer Statistics 2016 report, published by the American Cancer Society.
To change the course of this disease, the New York City Affiliate of the Pancreatic Cancer Action Network is inviting the community to attend PurpleStride New York City. The volunteer-led community celebration taking place on Saturday, April 9, through Brooklyn's Prospect Park will raise much needed awareness and funds to support the mission of the Pancreatic Cancer Action Network to advance research, support patients and create hope.
To register and to learn more visit www.purplestride.org/nyc.
"We're attending PurpleStride New York City because we've all been touched by pancreatic cancer," stated Jenny Kessman, spokesperson for the New York City Affiliate of the Pancreatic Cancer Action Network. "The survival rate is still in the single digits, at only 8 percent. Our community is joining together taking matters into our own hands as we wage hope at this celebratory event. PurpleStride empowers us to reach our goal – to double pancreatic cancer survival by 2020."
The family-friendly 5K timed awareness walk/run will include:
- Registration at 8 a.m., event begins at 9:15 a.m.
- Kid-friendly activities and "purple play zone"
- Opening ceremony featuring special guest – Good Morning America's Ron Claiborne
- Honorary Co-Chairs include: John D. Allendorf, MD, from Pancreas Health Program at Winthrop-University Hospital and Felice Schnoll-Sussman, MD, from Jay Monahan Center for Gastrointestinal Health at New York-Presbyterian/Weill Cornell Medicine
- Supporting Institution: Mount Sinai Health System
- Gold Sponsors:
- Halozyme Therapeutics
- NewLink Genetics
- Gold Media Sponsor: WABC-TV
- National Presenting Sponsor: Celgene
- National Silver Sponsor: AbbVie
The American Cancer Society reports an estimated 53,070 Americans will be diagnosed with pancreatic cancer and approximately 41,780 will die from the disease this year. The Pancreatic Cancer Action Network is working to double survival by 2020 by continuing to directly fund research, advocate for increased funding and resources from the national government, raise awareness through community outreach, and provide excellent patient services and support for novel initiatives like Clinical Trial Finder, Know Your TumorSM personalized medicine service and the Patient Registry.
Learn more about how you can support the local New York Affiliate and the Pancreatic Cancer Action Network by visiting www.pancan.org. Click to view this year's PurpleStride PSA and organizational PSA.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase survival for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double Pancreatic Cancer Survival by 2020. To continue to accelerate progress, a goal to raise $200 million by 2020 is also in place. Together, we can Wage Hope and rewrite the future of pancreatic cancer.
Public Relations Manager
Pancreatic Cancer Action Network
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-time-is-now-to-join-the-fight-against-pancreatic-cancer-at-purplestride-new-york-city-300244860.html
SOURCE Pancreatic Cancer Action Network